Afrezza may miss PDUFA date: Cowen, Piper

|By:, SA News Editor

Cowen and Piper are reportedly out expressing some skepticism about the chances of Afrezza approval by the PDUFA date.

The concern: The timing of the Ad Com (announced today) may leave too small of a window to get the inhalable insulin product reviewed by April 15.

Shares of MannKind (MNKD -15.5%) look to close sharply lower on the day.